Channelling investment into early phase human clinical trials of next generation treatments.
IMPACT AREA: Good health and well-being
Since the Snowdome Foundation’s founding in 2010, the Morris Family Foundation has been supporting the Centre of Research Excellence in Myeloma. This program has developed a new technology platform and software to enable greater understanding of how an individual’s cancer behaves than is currently achievable from existing technologies.
Over eight years, the Snowdome Foundation has provided access to next generation blood cancer treatment for 254 Australians. Their work has catalysed 15 clinical trials, and enabled 220 patients to participate in biomarker studies. The Snowdome Foundation won the 2016 National and Victorian Telstra Business Awards – Charity Division award for their work in making hope real in the fight against blood cancers.
The Centre of Research Excellence in Myeloma, led by Professor Miles Prince is a hub of expertise that allows high-quality researchers to collaborate within Australia and internationally. This disease-centric model of expertise was designed to lead towards a precision medicine model where knowledge sharing can lead to new ways of studying and treating blood cancers.